STAT3 and non-small cell lung carcinoma: Overall, the above results suggest that the endogenous expression of STAT3 plays an important role in determining the intrinsic sensitivity of lung cancer cells to taxane treatment, and that the expression levels of STAT3 may serve as a biomarker for predicting taxane response in NSCLC.